SUMMARY

The home health care system was only introduced in the Czech
Republic in 1991. It was a novelty, completely different from the
traditional public health care system based on hospital care.
Since 1991, the home health care sector has been growing very
rapidly. Further expansion of home health care is inevitable,
given the high costs of hospital health care and shortage of
financial resources in the health care system.

Driven by the need to decrease public health care costs, the
Czech government is considering decisions on closing some
hospitals or their parts. New legislation that is being prepared
by the Ministry of Health should support further development of
home health care.

Since the Czech home health care sector is still in its infancy,
there is a potential for U.S. firms, especially those offering a
wide variety of home care products, high-quality mobility
equipment and other novelties. Since domestic production only
satisfies around half of domestic demand for home care equipment,
the Czech Republic relies heavily on imports. Major medical
equipment manufacturers from the UK, Sweden, Germany,
Switzerland, Belgium, and other EU countries as well as some
firms from the USA have already established their presence in the
Czech Republic and offer a variety of high-quality products not
manufactured in the Czech Republic. Demand for home health care
products is expected to rise as the sector further develops.


A.  MARKET HIGHLIGHTS & BEST PROSPECTS

Market Profile

The Czech Republic's traditionally generous health care system,
based on hospital care, has been faced with decreasing financial
resources during the last several years. The system based on the
hospital beds does not correspond to the trends of modern
medicine and does not meet the needs of the aging Czech
population. Hospital care is being provided as either acute --
usually short-term or mid-term -- and post-treatment, usually
long-term.

Traditional diagnostic and acute health care is being replaced by
ambulant (non-resident) health care. The demand for acute
health-care hospital beds is therefore sharply declining, and the
number of these beds must be reduced. At the same time, there is
a lack of hospital beds for rehabilitation, recovery and
long-term care.

Changes to the health care system being prepared by the Ministry
of Health will involve designating some acute-care hospital beds
for post-treatment and reducing the total number of hospital beds
by 7,000 to 8,000. This will make it necessary to support
alternative methods of treatment, especially home health care,
for patients with long-term illnesses or post-treatment needs.

Home health care was introduced in the Czech Republic in 1991 in
order to reduce the demand for hospitalization and improve the
comfort and living standard of long-term patients, usually the
elderly. In 1991, 26 home health care agencies were established.
Since then, the home health care sector has developed
dynamically, and the number of home care agencies reached almost
500 in 1999. Almost 300 of these home care agencies offer 24-hour
service, 7 days a week. Apart from that, there are about 400
social service agencies offering some basic health care. A clear
division between home health care and social care has not been
defined yet, which also causes problems with financing.

At present, there are approximately 1,800 employees working in
home care agencies, the vast majority of them nurses. In 1998,
there were 106,811 patients taken care of by home care agencies,
49,376 patients partly dependent on care by others, 17,094 fully
dependent on others' care, and 40,341  able to care for
themselves. The number of home health care patients is expected
to rise by 10-20% a year in the coming years.

At present, at least 80% of these patients are elderly people age
65 or older, with chronic diseases, who require both health and
social care. The number of patients with acute diseases released
from hospitals to home health care is expected to rise in the
future, which will force home care agencies to buy more home care
medical equipment.

Home health care is fully reimbursed by health care insurance up
to 3 daily visits by a nurse to the patient's home. If a patient
requires more attention, he or she must pay. Home health care
agencies are paid from health care insurance according to the
reported operation. They can also obtain some additional funding
from state subsidies, sponsors and charity contributions.
However, home care agencies can only afford to buy basic medical
equipment and devices. It is critical to prove to government
officials that home care programs offer an efficient alternative
to traditional post-treatment and long-term care services, so
that the funding of home health care supports its further
development.

There is also a trend towards home care agencies joining together
to form larger agencies operating several units in different
places around the country. This will lower the operational costs
and allow purchases of more expensive medical equipment for the
use of all the units of one agency.

General knowledge of home health care medical equipment is still
low in the Czech Republic. Domestic production does not satisfy
the demand for these products, and the Czech Republic relies
heavily on imports. U.S. medical equipment is highly recognized
in the Czech Republic for its high quality and wide range of
specialized products adapted to meet the needs of different kinds
of patients. U.S. firms that established their presence here were
able to gain a significant market share in various niches of the
market and are often regarded as leaders in quality.

Professional connections between Czech and U.S. doctors, nurses,
home care agencies, professional associations and education
centers in the home care sector are very extensive. Czech
professionals often gain experience from their U.S. partners, and
the United States is considered the world's leader in the home
care sector. For these reasons, U.S. home care medical equipment
manufacturers have good opportunities to penetrate the Czech
market.


Statistical Data

Statistics do not exist for this sector.

Best Sales Prospects

The following product groups are considered to be the best sales
prospects in the coming years:

Daily care equipment, including thermometers, blood pressure
monitors, stethoscopes, glucometers.

Devices for immobile persons, including patient elevation,
transfer and handling equipment; self-mobility equipment,
including wheelchairs, walkers, crutches, canes, orthopedic
appliances and accessories; and in-house mobility equipment,
including elevators, ramps, stair-aids and accessories.

Best prospects among this group include hydraulic lifters for
elevation and transfer of patients and also ramps for dealing
with stairs and entering cars. Demand is especially high for
equipment that is multipurpose, extra light, easy to manipulate,
transport and store.

Bathroom safety equipment and hygienic devices, including
hygienic bath seating, safety rails, grab bars, raised toilet
seats, toilet-chairs, transferable bathtubs, bed baths,
underlying dishes and urine flasks.

There is an insufficient supply of inflatable bed baths with
compressors pumping hot water from a bucket on the floor to the
shower, with a discharger for the used water. There is a demand
for these baths with strong compressors and easy manipulation.

Infusion pumps, pumps for enteral nutriment, dialysis pumps and
dosing machines, including infusion dosing machines and dosing
machines all-in-one.

The competition is not yet very intense in the supply of infusion
pumps and dosing machines. There is no dominant Czech supplier,
and most devices are of foreign origin. Best prospects exist for
miniature pumps and dosing machines with easy manipulation, and
also for universal stands which would be easy to fix to any type
of bed, easy to manipulate and transport, mobile, stable, space
saving and storable.

Antidecubital supports, adjustable beds, chairs, therapeutic
mattresses.

There is a wide variety of sophisticated active antidecubital
supports on the market. However, cheap, durable, easy-to-wash and
manipulate supports are particularly popular. For example
supports of plastic foam with removable parts would be an
interesting product to introduce on the market.

Incontinence care products.

As single-use incontinence care products are beginning to be used
very widely, the problem arises with waste disposal, which is
very expensive. Demand for crushers of used products is expected
to rise.

Inhalators, oxygenators, and aspirators.

Lasers, magnets and devices for physiotherapy and rehabilitation.

Computer hardware and software, communication devices.

Most home health care agencies use only the basic documentation
and communication technology, including mobile phones and
computers. With further development and growth of home health
care agencies, demand will grow for more sophisticated
specialized documentation and communication devices.


B.  COMPETITIVE ANALYSIS

Domestic Production

The market for home care medical equipment is very dispersed.
Most firms supplying home care products offer only a narrow range
of the products they specialize in. Price is a key competitive
factor. However, there is a willingness to pay more for products
of considerably higher quality. Durability of the product is very
important, as is its ability to be easily transported, stored,
manipulated, maintained, and repaired. When introducing a new
product, promotion efforts must be intense.

Since the Czech home care sector is still in its infancy,
domestic medical equipment manufacturers lack experience with the
production of relevant equipment. Domestic producers are able to
satisfy approximately 50% of the market demand. The majority of
these producers are small to medium-sized businesses and do not
offer a wide range of products. The lower Czech labor costs
provide a major competitive advantage.

Major domestic producers:

Linet, Slany is a major Czech manufacturer of medical equipment.
It produces a wide range of adjustable beds, medical furniture,
devices for handling patients, etc. Linet has a significant
position in the market.

Ego, Zlin is a small producer of antidecubital sets and
mattresses, bed baths and wheelchair cushions.

CSO, Ostrava is a small producer of underlying dishes and urine
flasks, WC-chairs, hygienic seating baths, etc.

Medipo, Brno is a small manufacturer of infusion dosing machines.

Alfamedic, Lisov is a small producer of heated beds, inhalers and
drain-pumps.

Jevi Sport, Ceska Trebova is a small producer of adjustable beds
and furniture.

BMT, Brno is a medium-sized manufacturer of infusion dosing
machines.

Gama, Ceske Budejovice is a large producer of infusion sets,
dialysis sets, catheters, syringes, etc.

Brno Compact is a small producer of infusion and other pumps.

KlinLab, Praha is a medium-sized producer of inflatable bed
baths.

Inter-Meta, Ostrava is a small producer of a wide range of
antidecubital mattresses and bathroom safety equipment.


Third-Country Imports

There are several important foreign home care medical equipment
manufacturers competing actively in the Czech market. Most
successful are companies from the USA, UK, Sweden, Germany,
Switzerland, Belgium and other EU countries. Imports account for
approximately 50% of the total home health care market. Foreign
equipment is generally recognized as more reliable and of higher
quality than domestically produced products. Recognition of
foreign brand names is also very important. Competition is higher
in several market segments, for example, wheelchairs.

Foreign firms:

Hartmann-Rico, Veverska Bityska, German-Czech Company, majority
owned by German Hartmann, which acquired famous Czech medical
products manufacturer Rico, operates at present four factories in
the Czech Republic. Hartman also imports its products
manufactured in other countries around Europe. Hartman-Rico
divisions of hygienic products and incontinence care products
have dominant market shares.

Arjo Hospital Equipment of Sweden supplies a wide range of
products for hygiene systems, patient handling devices,
rehabilitation and antidecubital mattresses, through a Czech
distributor.

Vermeiren of Belgium supplies wheelchairs through a Czech
distributor.

Talley Medica of UK supplies antidecubital mattresses through a
Czech distributor.

Argus of Switzerland supplies infusion pumps through a Czech
distributor.

SCA Hygiene Products of Sweden is an important supplier of
incontinence products and has a significant market share.

Meyra of Germany supplies a full range of devices for immobile
patients. It has a significant market share.

DMA Days Medical of UK supplies a wide range of devices for
immobile patients, bathroom safety equipment, hygienic devices
and rehabilitation equipment. The products are price competitive
and widely used.


U.S. Market Position

U.S. products are viewed as very reliable and of top quality.
Price, limited availability of spare parts, and limited
after-sale training, maintenance, repair and other services are
disadvantages for U.S. exporters. U.S. companies that established
their presence in the Czech Republic overcame these difficulties
and were able to gain a significant share of some market
segments. There still exists a market for newcomers.

U.S. companies:

Convatec, a Bristol-Myers Squibb Company, has been present in the
Czech market since 1991. It operates here its three divisions
directed at home care: wound treatment, incontinence care
products for men, and treatment for patients with stomata.
Convatec's products are regarded as having the highest quality of
any on the market.

Abbot Laboratories supplies glucometers through a Czech
distributor.

MSM supplies two-way catheters.

Johnson&Johnson supplies therapeutical bandages for wounds and
chronic defects.

Dynamic Imaging supplies portable ultrasonic measurement devices
through a Czech distributor.

Aerosport supplies metabolic measurement systems through a Czech
distributor.

AVL supplies oxygenators through a Czech distributor.

Bird - A Thermo Electron Company supplies transport ventilators
through a Czech distributor.


C.  END-USER ANALYSIS

Patients in home care and their families are the primary
purchasers of home care medical equipment. Home health care
agencies also buy some equipment which nurses use during their
visits to the patients' homes or which they can lease to the
patients. Doctors play a decisive role, as they determine which
patients will be taken care of at home. From the 106,811 patients
diagnosed for home care in 1998, general practitioners decided in
94,663 cases, and in 12,148 cases specialized doctors gave the
home care diagnosis.

Doctors also decide which equipment and devices are the best for
given patients. Doctors choose equipment and devices from the
list prepared by General Health Insurance (Vseobecna zdravotni
pojistovna - VZP) every quarter of the year. The book also lists
the reimbursement for each item. It is therefore crucial for a
manufacturer to have its products listed in the VZP book. This
may be achieved through an agreement with VZP, which must be
renewed every 3 months (as new editions are published). It is the
manufacturer's responsibility to renew the agreement regularly,
so that the products are not set aside and omitted from the new
edition.

Firms negotiate very intensely with VZP to achieve the best
possible terms of reimbursement for the listed products. The best
outcome is when the product is fully reimbursed. In some cases,
VZP agrees to full reimbursement only under the condition of
further approval by an inspection doctor. This tends to be very
unfavorable, as the inspection doctors usually take at least a
month to decide, and the decision is often negative, with
recommendation for a cheaper product to be used in given cases.
Doctors therefore fear prescribing these kinds of products. If
full reimbursement of a product cannot be achieved without the
condition of the inspection doctor's approval, it is recommended
to try to get at least a partial reimbursement for the product.

Best marketing practices also involve establishment of a network
of contacts with Czech doctors, home care agencies, nurses, etc.,
and organizing regular visits and meetings for the purpose of
introducing new products, demonstrating the use of the equipment
and explaining all its advantages. Some companies even organize
regular seminars and other activities for home care agencies and
their nurses. This strategy has proven to be very successful, as
patients rely heavily on doctors' and nurses' recommendations
with regard to which medical equipment to be used in given cases.

Most in demand are devices and equipment that are fully
reimbursed. Price remains the key factor affecting users'
purchasing decisions, as most families still can not afford to
buy expensive equipment and devices if not reimbursed. This
situation will improve with the rebound of the Czech economy and
increase in family income. A product's high quality, durability,
versatility and after-sales service also influence buyers'
decisions.

The trend towards concentration among home care agencies will
also allow for purchases of more specialized and more expensive
equipment for the use of all the units of one agency.


D. MARKET ACCESS

Import Climate

There are no trade restrictions on imports of medical equipment,
devices and their components from the United States, other than
import duties. Import duties on medical equipment, devices and
components are generally very low, with the average between 1-3
%. However, U.S. imports face competition from imports from the
European Union countries, as most medical devices and equipment
produced in the EU can be imported into the Czech Republic with
no duty, due to the Association Agreement between the Czech
Republic and the EU. Some foreign producers use this advantage
and import medical devices and equipment to the Czech Republic
from their European production facilities.

Medical equipment, devices and their components are subject to a
preferential value-added tax of 5% only, which is actually paid
by end-users.

Registration process

All medical products offered in the Czech Republic must have a
certificate of approval to verify that the product meets Czech
standards. Such approval is issued by the State Institute for
Drug Control (SUKL). The producer, importer or distributor must
submit an application for registration/testing directly to SUKL.
SUKL then defines requirements for approval. Testing entails
mainly clinical tests, technical testing of electrical safety,
and tests of hygienic standards.

Some standards have already been harmonized with European Union
standards. The Czech Republic is in the process of harmonizing
its testing standards with the EU's and eventually, results of
testing carried out by an EU-approved facility will be recognized
by the Czech Ministry of Health. According to Czech law, SUKL has
a one-month period to decide on the registration of the product.
If the registration is issued, to be allowed to import the
product to the Czech Republic and distribute it here, a permit
for import and distribution is also necessary. It can be obtained
from the same institute (the same address).

State Institute for Drug Control
Statni ustav pro kontrolu leciv (SUKL)
Srobarova 48
100 41 Praha 10
Tel: 420-2-6731 1153
Fax: 420-2-744 944
Director: Milan Smid
E-mail: smid@sukl.anet.cz
Registration Department
Pharmaceuticals: Dr. Zuzana Rothova
Medical equipment: Dr. Jan Michalicek
Tel: 420-2-6708 2590
Fax: 420-2-7173 2377
Permit for import:
Contact person: Ms. Drahotova
Tel: 00420-2-6708-2791
Fax: 00420-2-7173-2377

If a new diskette is sent to the Registration Department, a
diskette with all rules and demands for registration and
certification will be sent back.

CE-marked Medical Devices Approval Requirements:

CE-marked medical devices are registered/approved in the Czech
Republic by a simplified procedure, the completion of which takes
considerably less time than the procedure used to
register/approve non-CE-marked products. Except for active
medical devices, where testing in the State laboratories is
prescribed by the law, no additional testing is required. Also,
no technical documentation has to be submitted. However, some
accurate descriptive information about the product, as well as
certain declarations made by the applicant, will still have to be
provided as part of the application.

Class I Medical Devices (non-sterile/non-measuring) Approval
Requirements:

Class I medical devices that are not sterile and/or have no
measuring function (as defined by the EU directive 93/42/EEC)
must be approved in the Czech Republic. A simplified procedure,
the completion of which takes considerably less time than the
procedure used for approval of medical devices in other
classification classes, is applied. The responsibility for this
type of device rests principally with the manufacturer of the
device. The device must meet the essential requirements set out
in Annex I of the directive 93/42/EEC, which apply to them,
taking into account the intended purpose of the device concerned.

The manufacturer must hold technical documentation that
demonstrates the conformity of the product with Annex VII of the
directive 93/42/EEC. This technical documentation must be
prepared prior to placing the product on the market and must be
made available by the applicant for review by the State Institute
for Drug Control. No technical documentation has to be submitted
as part of the application. Nevertheless, some accurate
descriptive information about the product will still have to be
filled in the application.


Distribution / Business Practices

The most common way to introduce a new product into the market is
to find or invest in a private distributor. The number of private
distributors has grown rapidly over the past few years, giving
U.S. companies many potential candidates from which to choose.
The most efficient distributors are those who work closely with
their foreign suppliers to develop a strategy that is tailored to
the nuances of the local market. This illustrates the
distributor's experience and knowledge of local pricing
strategies, level of advertising/promotion required and the
competition. In most cases, one distributor can provide coverage
throughout the entire country for a related line of products. If
local servicing or warehousing is required, a sub-distributor may
be required in certain parts of the country.

Support for the distributor by the U.S. exporter is crucial to
developing sales in the market. One example of this support is
for the U.S. company to assist in the financing of the product
into the distribution chain. One other example of support by the
U.S. firm is assistance with local advertising. In many cases,
foreign companies with local distributors provide the entire
local advertising support for the product, while the Czech
partner provides the physical facilities and equipment.


Financing

Most Czech firms are familiar with the most common methods of
international payment such as letters of credit, documentary
collections, and wire transfer/cash in advance.  Most would
prefer not to use a letter of credit due to its high cost,
especially in the case of smaller shipments.  The most common
methods are prepayment or partial prepayment with the balance due
upon delivery or net 30-day terms.  On very small shipments
(under $2,000) exporters might even consider allowing the buyer
to pay by credit card, which is being used more and more
frequently in the Czech Republic.  To compete with European
suppliers, American exporters should be willing to work with
their Czech buyers to provide flexible payment terms.  In this
regard, the export working capital programs provided by the Small
Business Administration, as well as export credit insurance
offered by the Export-Import Bank, may be helpful in allowing
U.S. exporters to offer more generous credit terms to their Czech
customers.

The U.S. Small Business Administration (SBA) has a number of
programs targeted toward helping small and medium-sized companies
to develop export markets.  In particular, SBA offers an export
working capital guarantee program, whereby SBA will guarantee up
to 75% of a bank loan to provide working capital or a line of
credit to exporters.  This, in turn, can enable exporters to
offer more favorable payment terms to their Czech buyers or
provide working capital while export orders are being
manufactured.

Contact:  In Washington, U.S. Small Business Administration, 409
Third Street, SW, Washington, DC 20416, Sheldon Snook, Office of
International Trade, Tel. (202) 205-6720, Fax: (202) 205-7272, or
call 1-800-USA-TRADE for the location of your nearest U.S. Export
Assistance Center.

The U.S. Export-Import Bank (EXIM) promotes the export of U.S.
goods and services through a variety of loan, guarantee, and
insurance programs.  All of its programs are available for the
Czech Republic. EXIM can guarantee U.S. commercial bank financing
for U.S. exporters and provide lines of credit to Czech buyers
through major Czech banks.  Its export insurance programs provide
insurance coverage against the risk of default on foreign
receivables.  In 1995, EXIM signed a co-financing agreement with
the Czech Export Bank (CEB). The agreement targets projects that
use both U.S. and Czech suppliers for products sold to a third
country.

Contact:  Export-Import Bank of the United States, 811 Vermont
Ave., NW, Washington, DC 20871; Tel.: (800) 565-EXIM (3946);
International Business Development Division; Tel.: (202)
565-3900; Fax: (202) 565-3946; International Lending Fax: (202)
565-3816, or call 1-800-USA-TRADE for the location of your
nearest U.S. Export Assistance Center.

Firms may also obtain commercial financing through the following
institutions, which have correspondent U.S. banking arrangements.

Ceskoslovenska Obchodni Banka
Ms Jana Svabenska, International Financing
Na prikope 14
115 20 Praha 1
Tel.  (420-2) 2411-1111
Fax.  (420-2) 2422-5049

Citibank
William Rocca, Corporate Finance
Evropska 178
160 00 Praha 6
Tel.  (420-2) 2430-4111
Fax.  (420-2) 2430-4613

Komercni Banka
Ms Olga Cudova, International Financing
Na prikope 33
114 07 Praha 1
Tel.  (420-2) 2243-2111
Fax.  (420-2) 2422-9359

Zivnostenska Banka
Mr. Johann Hombach, Project Financing
Na prikope 20
113 80 Praha 1
Tel.  (420-2) 2412-1111
Fax.  (420-2) 2412-5555


Key Contacts

MUDr. Michal Prokes
Director, Drugs and Medical Devices Regulation Department
Czech Ministry of Health
Palackeho namesti 4
128 01 Praha 2
Tel.: (420-2) 2497-2706
Fax: (420-2) 2491-5986

Ing. Jaroslav Rotbauer
Director, International Relations Department
Czech Ministry of Health
Palackeho namesti 4
128 01 Praha 2
Tel: (420-2) 2497 2457
Fax: (420-2) 2491 5430

Dr. Ludmila Subertova
Deputy Director, International Relations Department, U.S. Desk
Czech Ministry of Health
Palackeho namesti 4
128 01 Praha 2
Tel: (420-2) 2497 2699
Fax: (420-2) 2491 5430

Ms. Jindra Pavlicova
Chief Nursing Officer
Ministry of Health
Palackeho nam. 4
128 01 Praha 2
Tel.: (420-2) 2497-2555
Fax: (420-2) 2491-6004

State Institute for Drug Control
Statni ustav pro kontrolu leciv (SUKL)
Srobarova 48
100 41 Praha 10
Tel: (420-2) 6731 1153
Fax: (420-2) 744 944
Director: Milan Smid
E-mail: smid@sukl.anet.cz
Registration Department
Pharmaceuticals: Dr. Zuzana Rothova
Medical equipment: Dr. Jan Michalicek
Tel: (420-2) 6708 2590
Fax: (420-2) 7173 2377
Permit for import:
Contact person: Ms. Drahotova
Tel: (420-2) 6708-2791
Fax: (420-2) 7173-2377

Ms. Jirina Musilkova
Managing Director
General Health Insurance
Vseobecna zdravotni pojistovna (VZP)
Karlovo nam 8
128 01 Praha 2
Tel.: (420-2) 2491-5551
Fax: (420-2) 290-703

Dr. Vlasta Mazankova
Director
Institute of Health Information and Statistics
Palackeho namesti 4
128 01 Praha 2
Tel: (420-2) 2497 2243
Fax: (420-2) 2497 2244
E-mail: Mazankova@uzis.cz

Dr. Leos Heger
Chairman
Association of Hospitals
Fakultni nemocnice Kralovske Vinohrady
Srobarova 50
100 34 Praha 10
Tel, fax: (420-2) 6716 2942

Ms. Karolina Moravcova
President
Ms. Miroslava Horova
Vice-President
The Czech National Nurses' Association
I.interni klinika
U nemocnice 2
128 08 Praha 2
Tel.: (420-2) 290065, 2496-2529
Fax: (420-2) 297932
E-mail: mailto:r.wag.@vfn.cz

Ms. Hilda Vorlickova
President
The Czech Nurses Society
IDVPZ Vinarska 6
656 02 Brno
Tel: (420-5) 4332-1307
Fax: (420-5) 4321-1177

Ms. Blanka Miscoinova
President
National Center of Home Care
Home Care Association
Klimentska 11
115 60 Praha 1
Tel.: (420-2) 2480-2111
Fax: (420-2) 2480-2111


Trade Promotion Opportunities

MEFA - International Fair of Medical Instruments and Pharmacy
November 3-6, 1999
Organizer: BVV, a.s.
Contact name: Ms. Marie Trundova
Brnenske Veletrhy a Vystavy (BVV)
Vystaviste 1
602 00 Brno
Tel.: 00420-5-4115-2823
Fax: 00420-5-4115-3063
E-Mail: Mtrundov@bvv.cz
Http//www.bvv.cz

In 1999, the 7th MEFA and the 8th International Exhibition of
Rehabilitation, Compensation, Prosthetic and Orthopedic Aids will
be held. This is the Czech Republic's premier medical equipment
trade fair.

PRAGOMEDICA, PRAGOFARMA, PRAGOOPTIC, PRAGOLABORA, REHABILITACE
April 11 - 14, 2000
Organizer: Incheba Praha, s.r.o.
Contact name: Ms. Marcela Benesova
Opletalova 23
111 21 Praha 1
Tel.: (420-2) 2289-4255
Fax: (420-2) 2421-0798
E-mail: M.Benesova@incheba.cz
Http://www.incheba.cz

In 2000, the 22nd International Fair of Medical Technology for
Diagnostics and Therapy, Pharmaceutical Products, Optical Devices
and Equipment and Laboratory Devices and Equipment will be held.


Journals

Zdravotnicke noviny
Editor: Strategie Praha, s.r.o.
Contact person: PhDr. Jan Rezac
Drtinova 8
150 00 Praha 5
Tel.: (420-2) 5701-8111
Fax: (420-2) 5701-8439
E-mail: mailto:zdn@istrategie.cz
- Professional medical weekly magazine, especially for doctors

Sestra
Editor: Strategie Praha, s.r.o.
Contact person: Lenka Vitkova
Drtinova 8
150 00 Praha 5
Tel.: (420-2) 5701-8310
Fax: (420-2) 5701-0203
E-mail:mailto:zdn@istrategie.cz
- Professional medical magazine, especially for nurses, issued 9
times a year